Article
The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.
Journal of cutaneous pathology - 1 Sept 2021
Alomari Ahmed K, Tharp Andrew W, Umphress Brandon, Kowal Rachel P
Abstract excerpt
BACKGROUND: PRAME (PReferentially expressed Antigen in Melanoma) immunohistochemistry has demonstrated high specificity for unequivocal melanomas; however, its utility in ambiguous melanocytic neoplasms has yet to be fully elucidated. METHODS: Cases of challenging melanocytic neoplasms were subclassified into one of three categories: challenging, favor benign (FB), challenging, cannot be subclassified (CCS), or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
